RENEO PHARMACEUTICALS: Raises $50 Million to Develop Therapeutics to Treat Genetic Mitochondrial Diseases
Reneo Pharmaceuticals, a clinical stage pharmaceutical company, announced that it has completed a $50 million Series A financing to develop therapies for diseases associated with deficits in cellular metabolism and energy production. Read More »